Cardioneuroablation: Where are we at?
Status PubMed-not-MEDLINE Language English Country United States Media electronic-ecollection
Document type Journal Article
PubMed
37361615
PubMed Central
PMC10287999
DOI
10.1016/j.hroo.2023.02.007
PII: S2666-5018(23)00064-8
Knihovny.cz E-resources
- Keywords
- Autonomic nervous system, Cardioneuralablation, Cardioneuroablation, Functional bradycardia, Vasovagal syncope,
- Publication type
- Journal Article MeSH
Since its original description in 2005, catheter ablation techniques, commonly called cardioneuroablation, have emerged as a potential strategy for modulating autonomic function. Multiple investigators have provided observational data on the potential benefits of this technique in a variety of conditions associated with or exacerbated by increased vagal tone such as vasovagal syncope, functional atrioventricular block, and sinus node dysfunction. Patient selection, current techniques including the various mapping strategies, clinical experience, and limitations of cardioablation are reviewed. Finally, while cardioneuroablation has potential to be a treatment option for selected patients with symptoms mediated by hypervagotonia, the document outlines the important knowledge gaps that currently exist and the necessary next steps required before this technique can be widely implemented into clinical practice.
Arrhythmia Service Department of Cardiovascular Disease Mayo Clinic Jacksonville Florida
Dante Pazzanese Cardiology Institute São Paulo Heart Hospital São Paulo University São Paulo Brazil
Department of Cardiology Institute for Clinical and Experimental Medicine Prague Czech Republic
Department of Cardiology Yeditepe University Hospital Istanbul Turkey
See more in PubMed
Goldberger J.J., Arora R., Buckley U., Shivkumar K. Autonomic nervous system dysfunction: JACC Focus Seminar. J Am Coll Cardiol. 2019;73:1189–1206. PubMed PMC
Ackerknecht E.H. The history of the discovery of the vegatative (autonomic) nervous system. Med Hist. 1974;18:1–8. PubMed PMC
Coumel P. Paroxysmal atrial fibrillation: a disorder of autonomic tone? Eur Heart J. 1994;15:9–16. PubMed
Loomis T.A., Krop S. Auricular fibrillation induced and maintained in animals by acetylcholine or vagal stimulation. Circ Res. 1955;3:390–396. PubMed
Scherf D., Romano F.J., Terranova R. Experimental studies on auricular flutter and auricular fibrillation. Am Heart J. 1948;36:241–251. PubMed
Cannata D., Narbonne N.B. Clinical observations on the role of the vegetative nervous system in the pathogenesis of atrial fibrillation. Cardiologia (Basel) 1958;32:329–345. PubMed
Pachon J.C., Pachon E.I., Pachon J.C., et al. "Cardioneuroablation"--new treatment for neurocardiogenic syncope, functional AV block and sinus dysfunction using catheter RF-ablation. Europace. 2005;7:1–13. PubMed
Pachon M.J.C., Pachon M.E.I., Lobo T.J., et al. Syncopal high-degree AV block treated with catheter RF ablation without pacemaker implantation. Pacing Clin Electrophysiol. 2006;29:318–322. PubMed
Pachon -M.J.C. Cardioneuroablation for neurocardiogenic syncope. Heart Rhythm. 2019;16:1552–1553. PubMed
Aksu T., Guler T.E., Bozyel S., Yalin K., Gopinathannair R. Usefulness of post-procedural heart rate response to predict syncope recurrence or positive head up tilt table testing after cardioneuroablation. Europace. 2020;22:1320–1327. PubMed
Hu F., Zheng L., Liang E., et al. Right anterior ganglionated plexus: the primary target of cardioneuroablation? Heart Rhythm. 2019;16:1545–1551. PubMed
Aksu T., Gopinathannair R., Gupta D., Pauza D.H. Intrinsic cardiac autonomic nervous system: What do clinical electrophysiologists need to know about the "heart brain"? J Cardiovasc Electrophysiol. 2021;32:1737–1747. PubMed
Armour J.A., Murphy D.A., Yuan B.X., Macdonald S., Hopkins D.A. Gross and microscopic anatomy of the human intrinsic cardiac nervous system. Anat Rec. 1997;247:289–298. PubMed
Pauza D.H., Skripka V., Pauziene N., Stropus R. Morphology, distribution, and variability of the epicardiac neural ganglionated subplexuses in the human heart. Anat Rec. 2000;259:353–382. PubMed
Aksu T., Gupta D., Pauza D.H. Anatomy and physiology of intrinsic cardiac autonomic nervous system: Da Vinci anatomy card #2. J Am Coll Cardiol Case Rep. 2021;3:625–629. PubMed PMC
Kawano H., Okada R., Yano K. Histological study on the distribution of autonomic nerves in the human heart. Heart Vessels. 2003;18:32–39. PubMed
Xia Y., Zhao W., Yang Z.-J., et al. Catheter ablation of cardiac fat pads attenuates Bezold-Jarisch reflex in dogs. J Cardiovasc Electrophysiol. 2011;22:573–578. PubMed
Chiou C.W., Zipes D.P. Selective vagal denervation of the atria eliminates heart rate variability and baroreflex sensitivity while preserving ventricular innervation. Circulation. 1998 Jul 28;98:360–368. PubMed
Zhao Y., Jiang Z., Tsai W.C., et al. Ganglionated plexi and ligament of Marshall ablation reduces atrial vulnerability and causes stellate ganglion remodeling in ambulatory dogs. Heart Rhythm. 2016;13:2083–2090. PubMed PMC
Padmanabhan D., Naksuk N., Killu A.K., et al. Electroporation of epicardial autonomic ganglia: safety and efficacy in medium-term canine models. J Cardiovasc Electrophysiol. 2019;30:607–615. PubMed
Pachon M.J.C., Pachon M.E.I., Cunha Pachon M.Z., Lobo T.J., Pachon M.J.C., Santillana P.T.G. Catheter ablation of severe neurally meditated reflex (neurocardiogenic or vasovagal) syncope: cardioneuroablation long-term results. Europace. 2011;13:1231–1242. PubMed
Calo L., Rebecchi M., Sette A., et al. Catheter ablation of right atrial ganglionated plexi to treat cardioinhibitory neurocardiogenic syncope: a long-term follow-up prospective study. J Interv Card Electrophysiol. 2021;61:499–510. PubMed
Ulphani J.S., Arora R., Cain J.H., et al. The ligament of Marshall as a parasympathetic conduit. Am J Physiol Heart Circ Physiol. 2007;293:H1629–H1635. PubMed
Randall W.C., Ardell J.L., O'Toole M.F., Wurster R.D. Differential autonomic control of SAN and AVN regions of the canine heart: structure and function. Prog Clin Biol Res. 1988;275:15-31. PubMed
Pauziene N., Pauza D.H., Stropus R. Morphology of human intracardiac nerves: an electron microscope study. J Anat. 2000;197:437–459. PubMed PMC
Zheng L., Sun W., Liu S., et al. The diagnostic value of cardiac deceleration capacity in vasovagal syncope. Circ Arrhythm Electrophysiol. 2020;13 PubMed
Batulevicius D., Skripka V., Pauziene N., Pauza D.H. Topography of the porcine epicardiac nerve plexus as revealed by histochemistry for acetylcholinesterase. Auton Neurosci. 2008;138:64–75. PubMed
Piotrowski R., Baran J., Sikorska A., Krynski T., Kulakowski P. Cardioneuroablation for reflex syncope: efficacy and effects on autonomic cardiac regulation-a prospective randomized trial. J Am Coll Cardiol EP. 2023;9:85–95. PubMed
Pachon -M.E.I., Pachon-Mateos J.C., Higuti C., et al. Relation of fractionated atrial potentials with the vagal innervation evaluated by extracardiac vagal stimulation during cardioneuroablation. Circ Arrhythm Electrophysiol. 2020;13 PubMed
Huang X., Chen Y., Huang Y., et al. Comparative effects of intensive ganglionated plexus ablation in treating paroxysmal atrial fibrillation and vasovagal syncope. Clin Cardiol. 2020;43:1326–1333. PubMed PMC
Xu L., Zhao Y., Duan Y., et al. Clinical efficacy of catheter ablation in the treatment of vasovagal syncope. J Clin Med. 2022;11:5371. PubMed PMC
Tung R, Locke AH, Shah AD, et al. Feasibility and safety of catheter-based cardioneural ablation: results from the multicenter CAN registry. Presented at Heart Rhythm 2022; April 29–May 1, 2022; San Francisco, CA.
Debruyne P., Rossenbacker T., Janssens L., et al. Durable physiological changes and decreased syncope burden 12 months after unifocal right-sided ablation under computed tomographic guidance in patients with neurally mediated syncope or functional sinus node dysfunction. Circ Arrhythm Electrophysiol. 2021;14 PubMed PMC
Candemir B., Baskovski E., Beton O., et al. Procedural characteristics, safety, and follow-up of modified right-sided approach for cardioneuroablation. Anatol J Cardiol. 2022;26:629–636. PubMed PMC
Brignole M., Menozzi C., Del Rosso A., et al. New classification of haemodynamics of vasovagal syncope: beyond the VASIS classification. Analysis of the pre-syncopal phase of the tilt test without and with nitroglycerin challenge. Vasovagal Syncope International Study. Europace. 2000;2:66–76. PubMed
Pachon -M.J.C., Pachon -M.E.I., Pachon C.T.C., et al. Long-term evaluation of the vagal denervation by cardioneuroablation using Holter and heart rate variability. Circ Arrhythm Electrophysiol. 2020;13 PubMed
Tu B., Wu L., Hu F., et al. Cardiac deceleration capacity as an indicator for cardioneuroablation in patients with refractory vasovagal syncope. Heart Rhythm. 2022;19:562–569. PubMed
Yao Y., Shi R., Wong T., et al. Endocardial autonomic denervation of the left atrium to treat vasovagal syncope: an early experience in humans. Circ Arrhythm Electrophysiol. 2012;5:279–286. PubMed
Aksu T., Golcuk E., Yalin K., Guler T.E., Erden I. Simplified cardioneuroablation in the treatment of reflex syncope, functional AV block, and sinus node dysfunction. Pacing Clin Electrophysiol. 2016;39:42–53. PubMed
Mesquita D., Parreira L., Carmo P., et al. Anatomic guided ablation of the atrial right ganglionated plexi is enough for cardiac autonomic modulation in patients with significant bradyarrhythmias. Indian Pacing Electrophysiol J. 2021;21:327–334. PubMed PMC
Vandenberk B., Lei L.Y., Ballantyne B., et al. Cardioneuroablation for vasovagal syncope: a systematic review and meta-analysis. Heart Rhythm. 2022 Jun 16 [E-pub ahead of print] PubMed
Baysal E., Mutluer F.O., Dagsali A.E., Kumrulu U.C., Huang H.D., Aksu T. Improved health-related quality of life after cardioneuroablation in patients with vasovagal syncope. J Interv Card Electrophysiol. 2022 Nov 11 [E-pub ahead of print] PubMed
Fukunaga M., Wichterle D., Peichl P., Aldhoon B., Čihák R., Kautzner J. Differential effect of ganglionic plexi ablation in a patient with neurally mediated syncope and intermittent atrioventricular block. Europace. 2017;19:119–126. PubMed
Aksu T., Gopinathannair R., Bozyel S., Yalin K., Gupta D. Cardioneuroablation for treatment of atrioventricular block. Circ Arrhythm Electrophysiol. 2021;14 PubMed
Zhao L., Jiang W., Zhou L., et al. Atrial autonomic denervation for the treatment of long-standing symptomatic sinus bradycardia in non-elderly patients. J Interv Card Electrophysiol. 2015;43:151–159. PubMed
Qin M., Zhang Y., Liu X., Jiang W.F., Wu S.H., Po S. Atrial ganglionated plexus modification: a novel approach to treat symptomatic sinus bradycardia. J Am Coll Cardiol EP. 2017;3:950–959. PubMed
Vandenberk B., Morillo C.A., Sheldon R.S., Chew D.S., Aksu T., Raj S.R. Clinician needs and perceptions about cardioneuroablation for recurrent vasovagal syncope: an international clinician survey. Heart Rhythm. 2021;18:2160–2166. PubMed
Connolly S.J., Sheldon R., Roberts R.S., Gent M. The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol. 1999;33:16–20. PubMed
Connolly S.J., Sheldon R., Thorpe K.E., et al. VPS II Investigators. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial. JAMA. 2003;289:2224–2229. PubMed
Brignole M., Menozzi C., Moya A., et al. International Study on Syncope of Uncertain Etiology 3 (ISSUE-3) Investigators. Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial. Circulation. 2012 May 29;125:2566–2571. PubMed
Pournazari P., Sahota I., Sheldon R. High remission rates in vasovagal syncope: systematic review and meta-analysis of observational and randomized studies. J Am Coll Cardiol EP. 2017;3:384–392. PubMed
Abdelazeem B., Abbas K.S., Manasrah N., Amin M.A., Mohammed S.M., Mostafa M.R. Yoga as a treatment for vasovagal syncope: a systematic review and meta-analysis. Complement Ther Clin Pract. 2022;48 PubMed
Vyas A., Swaminathan P.D., Zimmerman M.B., Olshansky B. Are treatments for vasovagal syncope effective? A meta-analysis. Int J Cardiol. 2013 Sep 1;167:1906–1911. PubMed
Lei L.Y., Raj S.R., Sheldon R.S. Midodrine for the prevention of vasovagal syncope: a systematic review and meta-analysis. Europace. 2022;24:1171–1178. PubMed PMC
Mai W., Kusumoto F. Advanced atrioventricular block due to hypervagotonia: treatment with hyoscyamine. HeartRhythm Case Rep. 2022;8:343–346. PubMed PMC
Aksu T., Guler T.E., Mutluer F.O., Bozyel S., Golcuk S.E., Yalin K. Electroanatomic-mapping-guided cardioneuroablation versus combined approach for vasovagal syncope: a cross-sectional observational study. J Interv Card Electrophysiol. 2019;54:177–188. PubMed
Pachon M.J.C., Pachon M.E.I., Santillana P.T.G., et al. Simplified method for vagal effect evaluation in cardiac ablation and electrophysiological procedures. J Am Coll Cardiol EP. 2015;1:451–460. PubMed
Hou Y., Zhou Q., Po S.S. Neuromodulation for cardiac arrhythmia. Heart Rhythm. 2016;13:584–592. PubMed
Scanavacca M., Pisani C.F., Hachul D., et al. Selective atrial vagal denervation guided by evoked vagal reflex to treat patients with paroxysmal atrial fibrillation. Circulation. 2006;114:876–885. PubMed
Hu F., Yao Y. Cardioneuroablation in the management of vasovagal syncope, sinus node dysfunction, and functional atrioventricular block - techniques. J Atr Fibrillation. 2020;13:119–123. PubMed PMC
Piotrowski R., Zuk A., Baran J., Sikorska A., Krynski T., Kulakowski P. Ultrasound-guided extracardiac vagal stimulation-new approach for visualization of the vagus nerve during cardioneuroablation. Heart Rhythm. 2022;19:1247–1252. PubMed
Pachon -M.J.C., Ortencio F.A., Pachon -M.E.I., et al. Treatment of symptomatic functional atrioventricular block by cardioneuroablation as an alternative to pacemaker implantation. J Am Coll Cardiol Case Rep. 2022;4:990–995. PubMed PMC
Oh S., Zhang Y., Bibevski S., Marrouche N.F., Natale A., Mazgalev T.N. Vagal denervation and atrial fibrillation inducibility: epicardial fat pad ablation does not have long-term effects. Heart Rhythm. 2006;3:701–708. PubMed
Stavrakis S., Po S. Ganglionated plexi ablation: physiology and clinical applications. Arrhythm Electrophysiol Rev. 2017;6:186–190. PubMed PMC
Hanna P., Buch E., Stavrakis S., et al. Neuroscientific therapies for atrial fibrillation. Cardiovasc Res. 2021;117:1732–1745. PubMed PMC
Park H.W., Shen M.J., Lin S.F., Fishbein M.C., Chen L.S., Chen P.S. Neural mechanisms of atrial fibrillation. Curr Opin Cardiol. 2012;27:24–28. PubMed PMC